The caspase 8 inhibitor c-FLIPL modulates T-cell receptor-induced proliferation but not activation-induced cell death of lymphocytes

Molecular and Cellular Biology

Volumn 22, Issue 15, 2002, Pages 5419-5433

  Lens, Susanne M A ^a   Kataoka, Takao ^a   Fortner, Karen A ^a   Tinel, Antoine ^a   Ferrero, Isabel ^a   MacDonald, Robson H ^a   Hahne, Michel ^a   Beermann, Friedrich ^a   Attinger, Antoine ^a   Orbea, Hans Acha ^a   Budd, Ralph C ^a   Tschopp, Jürg ^a  

^a UNIVERSITY OF LAUSANNE   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; CASPASE 8; CD3 ANTIGEN; FAS LIGAND; FLICE INHIBITORY PROTEIN; T LYMPHOCYTE RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; CELL DEATH; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; ENZYME ACTIVITY; LYMPHOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TRANSGENIC MOUSE;

ANIMALS; ANTIGENS, CD3; ANTIGENS, CD4; ANTIGENS, CD45; ANTIGENS, CD8; APOPTOSIS; CARRIER PROTEINS; CASP8 AND FADD-LIKE APOPTOSIS REGULATING PROTEIN; CASPASE 8; CASPASE 9; CASPASES; CELL DIVISION; CELLS, CULTURED; ENZYME INHIBITORS; FAS LIGAND PROTEIN; FLOW CYTOMETRY; HUMANS; INTERLEUKIN-2; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LYMPHOCYTE ACTIVATION; MACROMOLECULAR SUBSTANCES; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED STRAINS; MICE, TRANSGENIC; PROTEIN ISOFORMS; RECEPTORS, ANTIGEN, T-CELL; T-LYMPHOCYTES;

ANIMALIA; MUS MUSCULUS;

EID: 0036310708     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.22.15.5419-5433.2002     Document Type: Article

References (64)

1. Fas ligand mediates activation-induced cell death in human T lymphocytes
2. Cell cycle-dependent regulation of FLIP levels and susceptibility to Fas-mediated apoptosis
3. Death receptors: Signaling and modulation
4. Constitutive NF-κB activation, enhanced granulopoiesis, and neonatal lethality in IκBα-deficient mice
5. Death effector domain-containing herpes-virus and poxvirus proteins inhibit both Fas- and TNFR1-induced apoptosis
6. Cell-autonomous Fas (CD95)/Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomas
7. Lpr and gld: Single gene models of systemic autoimmunity and lymphoproliferative disease
8. Assays of cell viability: Discrimination of cells dying by apoptosis
9. Autocrine T-cell suicide mediated by APO-1/(Fas/CD95)
10. Mammalian caspases: Structure, activation, substrates, and functions during apoptosis
11. Abnormal T lymphocyte development induced by targeted overexpression of IκBα
12. Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome
13. Fas ligand expression is restricted to nonlymphoid thymic components in situ
14. A specific intercellular pathway of apoptotic cell death is defective in the mature peripheral T cells of autoimmune lpr and gld mice
15. CASH, a novel caspase homologue with death effector domains
16. MRIT, a novel death-effector domain-containing protein, interacts with caspases and BclXL and initiates cell death
17. Reactive oxygen species regulate activation-induced T cell apoptosis
18. T cell receptor antagonist peptides induce positive selection
19. Fas triggers an alternative, caspase-8-independent cell death pathway using the kinase RIP as effector molecule
20. I-FLICE, a novel inhibitor of tumor necrosis factor receptor-1- and CD-95-induced apoptosis
21. CLARP, a death effector domain-containing protein interacts with caspase-8 and regulates apoptosis
22. Inhibition of death receptor signals by cellular FLIP
23. Fas(CD95)/FasL interactions required for programmed cell death after T-cell activation
24. The caspase-8 inhibitor FLIP promotes activation of NF-κB and Erk signaling pathways
25. FLIP prevents apoptosis induced by death receptors but not by perforin/granzyme B, chemotherapeutic drugs, and gamma irradiation
26. Caspase activation is required for T cell proliferation
27. A role for Fas in negative selection of thymocytes in vivo
28. Activation interferes with the APO-1 pathway in mature human T cells
29. Failure to regulate TNF-induced NF-κB and cell death responses in A20-deficient mice
30. Mature T lymphocyte apoptosis-immune regulation in a dynamic and unpredictable antigenic environment
31. Mouse mammary tumor virus: Immunological interplays between virus and host
32. Degree of ERK activation influences both positive and negative thymocyte selection
33. Immune escape of tumors in vivo by expression of cellular FLICE-inhibitory protein
34. An induced proximity model for caspase-8 activation
35. Apoptosis by death factor
36. A dominant interfering mutant of FADD/MCRTI enhances deletion of autoreactive thymocytes and inhibits proliferation of mature T lymphocytes
37. Religation of the T cell receptor after primary activation of mature T cells inhibits proliferation and induces apoptotic cell death
38. Cell death attenuation by 'Usurpin', a mammalian DED-caspase homologue that precludes caspase-8 recruitment and activation by the CD-95 (Fas, APO-1) receptor complex
39. Biochemical mechanisms of IL-2-regulated Fas-mediated T cell apoptosis
40. Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity
41. Anti-CD40L accelerates renal disease and adenopathy in MRL-lpr mice in parallel with decreased thymocyte apoptosis
42. Apoptosis signaling in lymphocytes
43. The role of c-FLIP in modulation of CD95-induced apoptosis
44. Apoptosis signaling by death receptors
45. Studies of T cell deletion and T cell anergy following in vivo administration of SEB to normal and lupus-prone mice
46. Simultaneous determination of cell surface antigens and apoptosis
47. Casper is a FADD- and caspase-related inducer of apoptosis
48. CrmA expression in T lymphocytes of transgenic mice inhibits CD95 (Fas/APO-1)-transduced apoptosis, but does not cause lymphadenopathy or autoimmune disease
49. FLAME-1, a novel FADD-like anti-apoptotic molecule that regulates Fas/TNFR1-induced apoptosis
50. Persistent activation of ERK contributes to glutamate-induced oxidative toxicity in a neuronal cell line and primary cortical neuron cultures
51. Bcl-2 and Fas/APO-1 regulate distinct pathways to lymphocyte apoptosis
52. Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand
53. Viral FLICE-inhibitory proteins (FLIPs) prevent apoptosis induced by death receptors
54. Turnover of naive- and memory-phenotype T cells
55. Inhibition of fas death signals by FLIPs
56. The fight of viruses against apoptosis
57. Autoimmunity as a consequence of retrovirus-mediated expression of C-FLIP in lymphocytes
58. A role for FADD in T cell activation and development
59. Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis
60. Expression of c-FLIP(L) and resistance to CD95-mediated apoptosis of monocyte-derived dendritic cells: Inhibition by bisindolylmaleimide
61. Requirement for Casper (c-FLIP) in regulation of death receptor-induced apoptosis and embryonic development
62. Fas-mediated apoptosis and activation-induced T-cell proliferation are defective in mice lacking FADD/Mortl
63. Induction of apoptosis in mature T cells by tumour necrosis factor
64. Target protease specificity of the viral serpin CrmA. Analysis of five caspases